These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 30035347)
21. Novel role of CD34+ stromal cells/telocytes in oral submucous fibrosis development and its malignant transformation. Kumar P; Thayalan D; Bose D; Krishnan R; Annasamy R; N I J Stomatol Oral Maxillofac Surg; 2024 Oct; 125(5S2):101990. PubMed ID: 39089508 [TBL] [Abstract][Full Text] [Related]
22. Quantitative dimensions of histopathological attributes and status of GSTM1-GSTT1 in oral submucous fibrosis. Pal M; Chaudhuri SR; Jadav A; Banerjee S; Paul RR; Dutta PK; Ghosh B; Chatterjee J; Chaudhuri K Tissue Cell; 2008 Dec; 40(6):425-35. PubMed ID: 18573513 [TBL] [Abstract][Full Text] [Related]
23. [A retrospective study of oral squamous cell carcinomas originated from oral submucous fibrosis]. Guo F; Jian XC; Zhou SH; Li N; Hu YJ; Tang ZG Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Aug; 46(8):494-7. PubMed ID: 22169748 [TBL] [Abstract][Full Text] [Related]
24. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Yang G; Rosen DG; Zhang Z; Bast RC; Mills GB; Colacino JA; Mercado-Uribe I; Liu J Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16472-7. PubMed ID: 17060621 [TBL] [Abstract][Full Text] [Related]
25. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition. Chang MC; Lin LD; Wu HL; Ho YS; Hsien HC; Wang TM; Jeng PY; Cheng RH; Hahn LJ; Jeng JH Carcinogenesis; 2013 May; 34(5):1096-104. PubMed ID: 23349021 [TBL] [Abstract][Full Text] [Related]
26. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study. Sudha VM; Hemavathy S Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045 [TBL] [Abstract][Full Text] [Related]
27. Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma. Hu X; Xiong H; Wang W; Huang L; Mao T; Yang L; Wang C; Huang D; Wu J; Xia K; Su T Arch Oral Biol; 2020 Apr; 112():104687. PubMed ID: 32114253 [TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 beta in oral submucous fibrosis, verrucous hyperplasia and squamous cell carcinoma tissues. Tsai CC; Chen CC; Lin CC; Chen CH; Lin TS; Shieh TY Kaohsiung J Med Sci; 1999 Sep; 15(9):513-9. PubMed ID: 10561975 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. Etemad-Moghadam S; Khalili M; Tirgary F; Alaeddini M J Oral Pathol Med; 2009 Sep; 38(8):639-43. PubMed ID: 19473444 [TBL] [Abstract][Full Text] [Related]
30. Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis. Bag S; Dutta D; Chaudhary A; Sing BC; Pal M; Ray AK; Banerjee R; Paul RR; Basak A; Das AK; Chatterjee J J Clin Pathol; 2018 Mar; 71(3):228-238. PubMed ID: 28821582 [TBL] [Abstract][Full Text] [Related]
31. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis. Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791 [TBL] [Abstract][Full Text] [Related]
32. Autofluorescence spectroscopy for the in vivo evaluation of oral submucous fibrosis. Haris PS; Balan A; Jayasree RS; Gupta AK Photomed Laser Surg; 2009 Oct; 27(5):757-61. PubMed ID: 19712020 [TBL] [Abstract][Full Text] [Related]
33. [Precancerous lesions of the buccal mucosa]. Ben Slama L Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145 [TBL] [Abstract][Full Text] [Related]
34. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. Chiu CJ; Chang ML; Chiang CP; Hahn LJ; Hsieh LL; Chen CJ Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):646-53. PubMed ID: 12101112 [TBL] [Abstract][Full Text] [Related]
35. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma. Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276 [TBL] [Abstract][Full Text] [Related]
36. Loss of oral mucosal stem cell markers in oral submucous fibrosis and their reactivation in malignant transformation. Sharma M; Fonseca FP; Hunter KD; Radhakrishnan R Int J Oral Sci; 2020 Aug; 12(1):23. PubMed ID: 32826859 [TBL] [Abstract][Full Text] [Related]
37. Profiling of chromosomal changes in potentially malignant and malignant oral mucosal lesions from South and South-East Asia using array-comparative genomic hybridization. Lunde ML; Roman E; Warnakulasuriya S; Mehrotra R; Laranne J; Vasstrand EN; Ibrahim SO Cancer Genomics Proteomics; 2014; 11(3):127-40. PubMed ID: 24969693 [TBL] [Abstract][Full Text] [Related]
38. Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer. Shintani S; Ishikawa T; Nonaka T; Li C; Nakashiro K; Wong DT; Hamakawa H Oncology; 2004; 66(4):316-22. PubMed ID: 15218300 [TBL] [Abstract][Full Text] [Related]
39. Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Jung DW; Che ZM; Kim J; Kim K; Kim KY; Williams D; Kim J Int J Cancer; 2010 Jul; 127(2):332-44. PubMed ID: 19937793 [TBL] [Abstract][Full Text] [Related]
40. Oral submucous fibrosis: An update on pathophysiology of malignant transformation. Arakeri G; Patil SG; Aljabab AS; Lin KC; Merkx MAW; Gao S; Brennan PA J Oral Pathol Med; 2017 Jul; 46(6):413-417. PubMed ID: 28391621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]